Objective To perform a meta-analysis of 4 core CSF biomarkers (β-amyloid [Aβ] 42, Aβ40,
total tau [t-tau], and phosphorylated tau [p-tau]) to assess which of these are most altered in …

Background To evaluate the diagnostic accuracy of cerebrospinal fluid (CSF) biomarkers in
patients with probable cerebral amyloid angiopathy (CAA) according to the modified Boston …

Background: There is limited data on cerebrospinal fluid (CSF) biomarkers in sporadic
amyloid-ß (Aß) cerebral amyloid angiopathy (CAA). Objective: To determine the profile of …

Objective Vascular amyloid β (Aβ) accumulation is the hallmark of cerebral amyloid
angiopathy (CAA). The composition of cerebrospinal fluid (CSF) of CAA patients may serve …

Background: There is no consensus regarding the diagnostic value of cerebrospinal fluid
(CSF) Alzheimer's disease (AD) biomarkers in cerebral amyloid angiopathy (CAA) …

Integrating cerebrospinal fluid-biomarkers into diagnostic workup of patients with sporadic
cerebral amyloid angiopathy may support early and correct identification. We aimed to …

According to the modified Boston criteria, cerebral amyloid angiopathy (CAA) can present
with lobar hematoma (LH) or superficial siderosis (SS). Recently, decreased CSF β-amyloid …

Objective Cerebral amyloid angiopathy-related inflammation (CAA-ri) is a rare manifestation
related to CAA, thought to be more severe. We aimed to compare the clinical and …

Introduction We performed a meta-analysis to synthesise current evidence on amyloid-
positron emission tomography (PET) burden and presumed preferential occipital distribution …

Background: There are limited data regarding the prevalence of distinct clinical,
neuroimaging and genetic markers among patients diagnosed with cerebral amyloid …